The role of vascular endothelial growth factor in neurodegeneration and cognitive decline: exploring interactions with biomarkers of Alzheimer disease.
The role of vascular endothelial growth factor in neurodegeneration and cognitive decline: exploring interactions with biomarkers of Alzheimer disease.
复制标题
血管内皮生长因子在神经退行性和认知下降中的作用:探索与阿尔茨海默氏病的生物标志物的相互作用。
DOI:
10.1001/jamaneurol.2014.4761
复制
发表时间:
2015-05
期刊:
影响因子:
29
通讯作者:
Jefferson, Angela L.
中科院分区:
文献类型:
--
作者:
Hohman, Timothy J.;Bell, Susan P.;Jefferson, Angela L.
A subset of older adults present post-mortem with Alzheimer’s disease (AD) pathologic features but without any significant clinical manifestation of dementia. Vascular endothelial growth factor (VEGF) has been implicated in staving off AD-related neurodegeneration. Evaluate whether VEGF levels are associated with brain aging outcomes (hippocampal volume, cognition). Further evaluate whether VEGF modifies relations between AD biomarkers and brain aging outcomes. Biomarker analysis using neuroimaging and neuropsychological outcomes from the Alzheimer’s Disease Neuroimaging Initiative (ADNI). Prospective longitudinal study across North America. Participants were drawn from the ADNI and included individuals with normal cognition (n=90), mild cognitive impairment (n=130), and AD (n=59). Cerebrospinal fluid (CSF) VEGF was cross-sectionally related to brain aging outcomes (hippocampal volume, episodic memory, executive function) using a general linear model and longitudinally using mixed-effects regression. AD biomarker (CSF amyloid-β42 and total tau) x VEGF interactions evaluated the effect of VEGF on brain aging outcomes in the presence of enhanced AD biomarkers. VEGF was associated with baseline hippocampal volume (p=0.009), longitudinal hippocampal atrophy (p=0.01), and longitudinal decline in memory (p<0.0001) and executive function (p=0.003). VEGF interacted with tau in predicting longitudinal hippocampal atrophy (p<0.0001), memory decline (p=0.01), and executive function decline (p=0.0002). VEGF interacted with amyloid-β42 in predicting longitudinal memory decline (p=0.01). Elevated CSF VEGF was associated with more optimal brain aging in vivo. The neuroprotective effect appeared strongest in the presence of enhanced AD biomarkers, suggesting that VEGF may be particularly beneficial in individuals showing early hallmarks of the AD cascade. Future work should evaluate the interaction between VEGF expression in vitro and pathologic burden to address potential mechanisms.
登录
查看更多内容
影响因子:
5.7
作者:
Fischl, B;Sereno, MI;Dale, AM
通讯作者:
Dale, AM
影响因子:
3.2
作者:
Crane, Paul K.;Carle, Adam;Gibbons, Laura E.;Insel, Philip;Mackin, R. Scott;Gross, Alden;Jones, Richard N.;Mukherjee, Shubhabrata;Curtis, S. McKay;Harvey, Danielle;Weiner, Michael;Mungas, Dan
通讯作者:
Mungas, Dan
影响因子:
5.7
作者:
Reuter, Martin;Schmansky, Nicholas J.;Rosas, H. Diana;Fischl, Bruce
通讯作者:
Fischl, Bruce
影响因子:
12.7
作者:
Shaw LM;Vanderstichele H;Knapik-Czajka M;Figurski M;Coart E;Blennow K;Soares H;Simon AJ;Lewczuk P;Dean RA;Siemers E;Potter W;Lee VM;Trojanowski JQ;Alzheimer's Disease Neuroimaging Initiative
通讯作者:
Alzheimer's Disease Neuroimaging Initiative
影响因子:
9.9
作者:
Jagust, W. J.;Landau, S. M.;Mathis, C. A.
通讯作者:
Mathis, C. A.